|
J Biol Chem, Vol. 275, Issue 17, 12769-12780, April 28, 2000
High Density Lipoprotein-mediated Cholesterol Uptake and
Targeting to Lipid Droplets in Intact L-cell Fibroblasts
A SINGLE- AND MULTIPHOTON FLUORESCENCE APPROACH*
Andrey
Frolov ,
Anca
Petrescu§,
Barbara P.
Atshaves§,
Peter
T. C.
So¶,
Enrico
Gratton ,
Ginette
Serrero**, and
Friedhelm
Schroeder§
From the Department of Pathobiology, the
§ Department of Physiology and Pharmacology, Texas A & M
University, Texas Veterinary Medical Center, College Station, Texas
77843-4466, the ¶ Department of Mechanical Engineering,
Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, and the Laboratory for Fluorescence Dynamics, Department of
Physics, University of Illinois, Urbana, Illinois 61801, and the
** Department of Pharmaceutical Sciences, University of Maryland School
of Pharmacy, Baltimore, Maryland 21201-1180
 |
ABSTRACT |
Fluorescent sterols, dehydroergosterol and
NBD-cholesterol, were used to examine high density lipoprotein-mediated
cholesterol uptake and intracellular targeting in L-cell fibroblasts.
The uptake, but not esterification or targeting to lipid droplets, of
these sterols differed >100-fold, suggesting significant differences in uptake pathways. NBD-cholesterol uptake kinetics and
lipoprotein specificity reflected high density lipoprotein-mediated
sterol uptake via the scavenger receptor B1. Fluorescence energy
transfer showed an average intermolecular distance of 26 Å between the two fluorescent sterols in L-cells. Indirect
immunofluorescence revealed that both fluorescent sterols localized to
L-cell lipid droplets, the surface of which contained adipose
differentiation-related protein. This lipid droplet-specific protein
specifically bound NBD-cholesterol with high affinity
(Kd = 2 nM) at a single site. Thus,
NBD-cholesterol and dehydroergosterol were useful fluorescent probes of
sterol uptake and intracellular sterol targeting. NBD-cholesterol more
selectively probed high density lipoprotein-mediated uptake and
rapid intracellular targeting of sterol to lipid droplets. Targeting of
sterol to lipid droplets was correlated with the presence of adipose
differentiation related protein, a lipid droplet-specific protein shown
for the first time to bind unesterified sterol with high affinity.
 |
INTRODUCTION |
Because of cholesterol's dual role in both normal cell function
and the pathobiology of atherosclerosis, it is essential to resolve the
mechanisms whereby exogenous cholesterol is taken up and distributed
within the cell (reviewed in Refs. 1-3). Unesterified cholesterol
uptake shares some, but not all, aspects of cholesterol ester uptake.
Unesterified cholesterol enters the cell either by the slower
LDL1 receptor mediated
pathway wherein it leaves the LDL endocytosed within clathrin-coated
vesicles prior to vesicle fusion at the lysosome (for review, see Ref.
3) or by the rapid "alternate" HDL receptor pathway (3, 5).
However, most attention has focused on the HDL-mediated cholesterol
efflux from rather than uptake of cholesterol into the cell (for
review, see Ref. 4). Almost nothing is known regarding the uptake and
intracellular targeting of unesterified cholesterol via the HDL
receptor pathway nor has the process been directly visualized.
Fluorescent cholesterol analogs represent an opportunity for real-time
monitoring of the rapid, HDL-mediated uptake of unesterified sterol
uptake and movement in living cells. The main requirement for choice of
an appropriate fluorescent cholesterol analogue is that it should mimic
the behavior of cholesterol. Unfortunately, the functional properties
of many fluorescent sterol analogues do not closely resemble those of
cholesterol (for review, see Refs. 6-9). The advent of
dehydroergosterol (DHE), whose structure closely resembles that of
cholesterol, represents a major advance for examining the structure of
lipoproteins (10, 11) and membranes (12). DHE is a naturally occurring
sterol where it comprises >20% of sterols in certain animals (yeast
and sponge) and can replace up to 85% of cultured L-cell fibroblast
cholesterol without altering cell growth, membrane function, or
membrane lipid composition (for review, see Ref. 6). Furthermore, DHE
codistributes with cholesterol in model (2, 6, 13-15) and biological
membranes (2, 16-19), desorbs from membranes with very similar
kinetics as does cholesterol, and both cholesterol and DHE are
esterified in L-cells (2). Finally, DHE readily incorporates into rat, rabbit, or human VLDL, LDL, and HDL either in vitro (10, 11, 20, 21) or in vivo (21, 22) to reflect the organization of
cholesterol and its interactions with apoproteins therein.
Despite the more than two decades wherein DHE was used to determine
lipoprotein and membrane structure, only recently were confocal laser
scanning microscopy (16) and conventional fluorescence microscopy (23)
used to directly visualize intracellular DHE distribution in
living cells. It was concluded that DHE colocalized with cholesterol in
living cells (23). As both these studies pointed out, however, DHE has
very significant disadvantages for use in conventional and confocal
microscopy in that DHE requires excitation in the UV region (325 nm) of
the spectrum where it becomes severely photobleached.
In the present investigation the disadvantages of UV excitation for DHE
were overcome through the use of multiphoton excitation and multiphoton
laser scanning microscopy (MLSM). Furthermore, NBD-cholesterol
(NBD-chol) proved to be an alternate fluorescent cholesterol analog to
visualize HDL-mediated uptake and intracellular targeting of
unesterified cholesterol in L-cell fibroblasts. NBD-chol is absorbed by
the intestine of hamsters fed NBD-chol as well as by cultured Caco-2
cells (24). In contrast to DHE, the literature with regard to NBD-chol
esterification is more complex. NBD-chol is esterified in
vitro by acyl-CoA cholesterol acyltransferase of hamster
intestinal microsomes (24), but not rat liver microsomes (25).
Furthermore, NBD-chol is esterified in hamster intestine and cultured
Caco-2 intestinal cells (24).
Based on the above findings, the fluorescence properties of DHE and
NBD-chol as well as cultured L-cell fibroblasts, a cell line that grows
in serum-free medium (26), were used to (i) compare the uptake and
esterification of these sterols in the same cell type, (ii) determine
if uptake of either fluorescent sterol was characteristic of HDL
receptor mediated uptake, (iii) resolve the specificity of
intracellular targeting of fluorescent sterol, and (iv) begin to
determine the molecular basis for trafficking of cholesterol to lipid droplets.
 |
EXPERIMENTAL PROCEDURES |
Materials--
DHE was obtained from Sigma or synthesized as
described earlier (27). In either case, purity was monitored by HPLC
(27) and only DHE with purity >96% was used for the studies presented herein. [3H]Cholesterol was purchased from NEN Life
Science Products Inc. (Boston, MA). Human plasma high density
lipoproteins (HDL), low density lipoprotein (LDL), and very low density
lipoprotein (VLDL) were obtained from Calbiochem, La Jolla, CA.
NBD-cholesterol (NBD-Chol), [22-(N-7-nitrobenz-2-oxa-1,3-diazo-4-yl)-amino-23,24-bisnor-5-cholen-3 -ol))], Nile Red, and Alexa 594 goat anti-mouse IgG conjugate were supplied by
Molecular Probes (Eugene, OR). Polyclonal and monoclonal
anti-caveolin-1 IgM and IgG antibodies were from Transduction Labs
(Lexington, KY). Polyclonal anti-scavenger receptor BI (SRB1) antibody
was obtained from Novus Biologicals (Littleton, CO). Affinity purified rabbit polyclonal antisera to recombinant mouse adipocyte
differentiation-related protein (ADRP) were provided by Dr. G. Serrero
(University of Maryland, Baltimore, MD). Alkaline phosphatase and
fluorescein isothiocyanate conjugates of goat anti-mouse as well as
rabbit IgG and IgM were purchased from Sigma. Texas Red goat
anti-rabbit IgG conjugate was from Molecular Probes (Eugene, OR).
Nitrocellulose membrane was purchased from Schleicher & Schuell (Keene,
NH). All other chemical were reagent grade or better.
Cell Culture and Incorporation of DHE or NBD-chol for
Fluorescence Imaging--
L-cells
(L-arpt tk ) were maintained in Higuchi
medium containing 10% fetal bovine serum as described elsewhere (28).
For laser scanning confocal microscopy (LSCM) and MLSM colocalization experiments the L-cells were cultured on Lab-Tek chambered slides (VWR,
Sugarland, TX) in Higuchi medium with 10% FBS to which fluorescent sterol was added as indicated. The fluorescent sterols, prepared as
ethanolic stock solutions (5-10 mg/ml) containing 1 mol % butylated hydroxytoluene and stored at 70 °C, were then added to the cell culture medium as described earlier (12, 18). The final ethanol concentration was maintained at <0.1%, a level that did not affect cell growth. The choice of fluorescent sterol concentrations for the
imaging studies was dictated as follows: (i) because of the low
intensity of DHE signal for multiphoton imaging, it was not possible to
obtain useable images from cells preincubated with low concentrations
(5 µg of DHE/ml of medium). (ii) The use of high levels of NBD-chol
(15 µg/ml) in the culture medium cell was prohibitive since it
diminished growth and altered cell morphology. Therefore, the L-cells
were preincubated in 10% FBS containing medium with or without DHE (15 µg/ml), NBD-chol (5 µg/ml), or (15 µg of DHE +5 µg
NBD-chol)/ml, for either 24 or 48 h at 37 °C. After
preincubation the L-cells were washed three times with phosphate-buffered saline to remove unbound probe(s) and transferred to
Higuchi medium (26) without pH indicator.
Western Blot Analysis of Caveolin 1, SRB-I, and ADRP in
L-cells--
Cells were lysed in 2% SDS, 10% glycerol in 62.5 mM Tris-HCl, pH 6.8. Protein concentration in cell lysates
was estimated by BCA-200 protein assay (Pierce). SDS-polyacrylamide gel
electrophoresis was performed on gels containing 40 µg of
protein/lane: 16% acrylamide (for caveolin) and 12% acrylamide (for
SRB-I and ADRP) (29). Proteins were transferred to nitrocellulose
membrane and blots were blocked with: (i) 3% gelatin in TBST (10 mM Tris-HCl, pH 8, 100 mM NaCl, 0.05% Tween
20) when monoclonal anti-caveolin IgM was used; (ii) 0.2% dry milk,
1% gelatin in TBS (TBST without Tween 20) when polyclonal rabbit
anti-SRB-I and anti-ADRP were used as primary antibodies.
Alkaline-phosphatase conjugates of appropriate secondary antibodies and
Western Blue substrate (Promega, Madison, WI) were used to visualize
the bands of interest.
NBD-cholesterol Binding to ADRP--
Recombinant mouse ADRP used
in this experiment was purified according to Serrero et
al.2 The affinity of
ADRP for NBD-chol was determined using a steady state photon counting
fluorimeter (see below) according to a modification of a previously
described procedure (30). Briefly, ADRP was added to a 2-ml sample of
phosphate buffer (10 mM, pH 7.4) to a final concentration
of 11.1 nM. Small increments (0.5-2.0 µl) of NBD-chol
(0.14 µM in dimethylformamide) were then added and each
sample and blank (without ADRP) were mixed and equilibrated at 25 °C
for 2-4 min for stable measurement of fluorescence. NBD-chol was
excited at 465 nm (8 nm slits) and fluorescence emission spectra were
recorded from 500 to 600 nm (16 nm slits). The NBD-chol fluorescence emission was integrated after each addition of the ligand and corrected
for the blank and background. This allowed binding isotherm construction and fitting using a simple, single binding site model as
described (30).
Preparation of Cells for Indirect Immunofluorescence
Microscopy--
L-cells, cultured as described above, were washed with
Hank's buffer and fixed in 2% (w/v) paraformaldehyde in Hank's
buffer for 30 min at room temperature. In some experiments cells were permeabilized with 0.1% Triton X-100 for 5 min at 4 °C. Cells were
then blocked sequentially with 0.2 M glycine for 30 min, and with 0.2 mg/ml goat IgG and 2% bovine serum albumin in Hank's buffer (BSA/Hank's) for 1 h at room temperature. Primary
antibodies (monoclonal anti-caveolin-1 IgG and IgM, and rabbit
polyclonal anti-SR-BI) were diluted 1:50 in BSA/Hank's and incubated
with cells for 2 h at room temperature. Cells were washed three
times for 10 min with BSA/Hank's. Secondary antibodies (Alexa,
fluorescein isothiocyanate, or Texas Red-labeled goat anti-mouse or
rabbit IgG or IgM) were diluted 1:200 in BSA/Hank's and incubated with cells for 1 h at room temperature. Finally, cells were washed and
mounted by using the SlowFade kit from Molecular Probes (Eugene, OR).
Control experiments included: (i) the lack of specific staining of
L-cells with secondary antibody in the absence of primary antibody and
(ii) the lack of specific staining of L-cells with preimmune antisera
followed by incubation with secondary antibody as described above.
In experiments performed to assess the level of co-localization of ADRP
with NBD-chol, L-cells were incubated with 5 µg/ml NBD-chol in
Higuchi medium (26) for 48 h prior to fixation in acetone:ethanol
mixture (70:30) for 10 min at 4 °C. Cells were then permeabilized
with 0.05% saponin for 5 min at room temperature, blocked with 5% FBS
in Hank's and incubated with polyclonal rabbit anti-mouse ADRP for
1 h at room temperature. Since NBD-chol has a green fluorescence,
Texas Red-conjugated goat anti-rabbit IgG was used to visualize ADRP as
red fluorescence; incubation with secondary antibody was for 1 h
at room temperature. Cells were then mounted in SlowFade solution as
described above.
MLSM and Image Analysis--
Multiphoton excitation and MLSM and
fluorescence imaging of DHE and NBD-chol was performed on intact
L-cells cultured as described above on Lab-Tek chambered slides (VWR,
Sugarland, TX). MLSM fluorescence imaging was performed as described
elsewhere (31, 32). Briefly, the excitation source was a femtosecond
Mira 900 Ti-sapphire laser (Coherent, Palo Alto, CA) pumped at 8 W with
an Innova 308 argon ion laser (Coherent, Palo Alto, CA). The Mira 900 Ti-sapphire laser was tuned to emit at 730 or 960 nm, as indicated in
the text. The excitation light was delivered to an Axiovert 35 (Zeiss Inc., New York) microscope stage via a modified epiluminescence light
path. A Zeiss ×40 Plan-Fluor (1.3 N.A., oil) objective was used for
high resolution imaging. The fluorescence signal was collected by the
same objective, transmitted through the dichroic mirror and barrier
filter (450 SP or 550 LP; CVI Laser, Corp., Albuquerque, NM), and
refocused on a low noise, single photon counting R5600-P
photomultiplier tube (Hamamatsu, Bridgewater, NJ). Data presentation
was performed using MetaMorph Image Analysis Software (Advanced
Scientific Imaging, Meraux, LA).
LSCM and Image Analysis--
LSCM studies were performed on a
MRC-1024 fluorescence imaging system (Bio-Rad). The system was based on
an Axiovert 135 microscope (Zeiss) equipped with three independent
low-noise photomultiplier tube channels. The excitation light, = 488 nm, from a 15 mW krypton-argon laser (5 mW all lines, measured at
the microscope stage) was delivered to the sample through ×63 Zeiss
Plan-Fluor oil immersion objective, numerical aperture 1.45. Images
were acquired and analyzed using LaserSharp software (Bio-Rad) and MetaMorph Image Analysis Software (Advanced Scientific Imaging, Meraux, LA).
NBD-cholesterol Uptake Kinetics--
NBD-chol uptake kinetics
were obtained by LSCM fluorescence microscopy on single, living cells.
Cells grown to a subconfluent monolayer on chambered coverslips (see
above) were washed with Puck's buffer followed by incubation for the
indicated time in serum-free, pH indicator-free Higuchi medium without
or with the indicated concentration of the following lipid vehicles:
FBS, HDL, VLDL, LDL, or BSA. An area on the coverslip chamber
containing 5-10 cells was randomly selected with the microscope and
the position of the objective was focused to view the median section of
the cells. Cholesterol influx was initiated by addition of NBD-chol followed by acquisition of digitally acquiring images at intervals of
30-60 s using TimeCourse Software (Bio-Rad).
Kinetic Analysis of the Time Course of NBD-Chol
Uptake--
NBD-chol uptake was monitored in single cells as described
above and the cell average pixel intensity as a function of time was
determined with the help of TimeCourse Software (Bio-Rad). The
calculated kinetic parameter values were expressed as mean ± S.E.
Statistical analysis was performed using Student's t test using the SigmaPlot software (SPSS Inc., Chicago, IL). The kinetics of
NBD-chol uptake by L-cells were analyzed by nonlinear regression. The
data were best fitted (r2 = 0.999) to the
Hill's equation describing cooperative kinetic process,
|
(Eq. 1)
|
where F is the intracellular NBD-chol fluorescence
intensity expressed as average pixel intensity in gray scale units;
t is the time following the initiation of the influx by
addition of NBD-chol; a, b, and c are kinetic
parameters describing, respectively, the saturation maximum level,
Hill's coefficient, and the time required to reach 50% of the
saturation maximum level (t50).
Absorption Spectroscopy--
Absorption spectra were recorded on
a computer-controlled dual-beam UV-VIS Lambda 2 spectrophotometer
(Perkin-Elmer, Norwalk, CT). The background and light scatter
correction of the absorption spectra were performed using SigmaPlot
software (SPSS Inc., Chicago, IL).
Steady-state Fluorescence Spectroscopy for NBD-chol Binding and
Displacement--
For NBD-chol binding experiments to ADRP, increasing
concentrations of NBD-chol (from 0 to 100 nM) were
incubated for 2 min in 25 mM phosphate buffer in the
absence or presence of 70 nM ADRP. Emission spectra were
then obtained from 500 to 600 nm upon NBD-chol excitation 473 nm. For
displacement assays, the ADRP (70 nM) was preincubated with
NBD-cholesterol (7 nM) in 25 mM phosphate
buffer for 5 min, followed by addition of increasing concentrations of
cholesterol (from 0 to 46.5 nM). The spectra were corrected
for unbound NBD-cholesterol fluorescence and light scatter. Excitation
was at 473 nm while integrative fluorescence intensity was measured for
emission >500 nm with a PC1 Photon Counting Spectrofluorometer (ISS
Instruments, Champaign, IL) in the ratio mode. Unless otherwise
specified, sample temperature was 25 °C (± 0.1 °C) in a
thermostatted cell holder. Excitation and emission bandwidths were 4 and 8 nm. Sample absorbance at the excitation wavelengths was < 0.05.
Fluorescence Resonance Energy Transfer (FRET) and the
Intermolecular Distance between Dehydroergosterol and
NBD-chol--
For determination of the average intermolecular distance
between DHE and NBD-chol, L-cells were grown under the same conditions used for fluorescence imaging described above: 10% FBS medium with or
without DHE (15 µg/ml), NBD-chol (5 µg/ml), or (15 µg of DHE + 5 µg of NBD-chol/ml) for 24 h.
The critical distance for energy transfer, R0,
for the DHE and NBD-chol donor/acceptor pair was calculated a according
to Equation 2 (33),
|
(Eq. 2)
|
where Q is the quantum yield of the donor in the
absence of the acceptor; n, the refractive index;
J, the overlap integral defined as,
|
(Eq. 3)
|
where FD( ) is the normalized emission
spectrum of the donor; A( ) is the absorption spectrum of
the acceptor. K2 is the orientation factor
ranging from 0 to 4. Giving the n = 1.4, Q = 0.25 (34), and K2 = 2/3, the
critical energy transfer distance for the DHE and NBD-chol
donor/acceptor pair was calculated to be 25.8 Å. Energy transfer
efficiency, E, is related to the distance between the donor
and the acceptor r by,
|
(Eq. 4)
|
HPLC Analysis of Lipids Extracted from Cell Culture--
The
extent of esterification of [3H]cholesterol,
NBD-cholesterol, and DHE was determined by analyzing lipid samples by
HPLC. Cell monolayers from L-cells were incubated with either
[3H]cholesterol (0.1 µCi/ml medium), NBD-cholesterol (5 µg/ml medium), or DHE (15 µg/ml medium) for 24 h followed by
lipid extraction into n-hexane/2-propanol (3:2) (v/v) (35).
The protein portion was separated by centrifugation (800 × g), air-dried, resuspended in 0.2 N KOH, heated
overnight at 65 °C, and then quantified for content (36). In order
to isolate the neutral lipid classes, the supernatant was evaporated
under nitrogen, resuspended in chloroform/methanol (59:1), and applied
to a silicic acid column. The eluate was evaporated to dryness, brought
up in hexane (98.7), isopropyl alcohol (1.2), glacial acetic acid
(0.5), hexane (75:25) (v/v), and injected onto a Luna 5-µm Silica (2)
column (Phenomenex, Torrance, CA). Data was analyzed by software from
Dionysis Peak net (37, 38).
 |
RESULTS |
Uptake and Intracellular Esterification of Dehydroergosterol and
NBD-chol in L-cell Fibroblasts--
Two fluorescent sterols, DHE and
NBD-chol, were used herein to directly visualize sterol uptake as well
as intracellular sterol distribution and targeting. DHE is a naturally
occurring fluorescent sterol while NBD-chol is a synthetic sterol
containing the NBD reporter group attached in the alkyl chain of
cholesterol. Because of the use of different in vitro and
in vivo conditions in the literature (see Introduction), it
is difficult to compare their relative uptake and/or esterification.
Therefore, DHE and NBD-chol uptake and intracellular esterification
were compared in the same cell line, L-cell fibroblasts, and under the
same conditions used for the fluorescence imaging and fluorescence
resonance energy transfer studies described in the following sections.
The extent of DHE and NBD-chol taken up by L-cells differed markedly.
When cultured in 10% FBS serum supplemented with 5 or 15 µg of
DHE/ml medium, respectively, L-cells took up 13.5 ± 1.2 (n = 5) and 73.5 ± 13.2 (n = 4)
pmol of DHE/mg of cell protein, respectively. While morphological and
cell growth changes precluded determination at high NBD-chol (15 µg
of NBD-chol/ml medium), L-cells grew normally at 5 µg of NBD-chol/ml
medium and took up 0.16 ± 0.01 pmol of NBD-chol/mg cell protein
(n = 5). Thus, total uptake of DHE was 84- and
>100-fold, respectively, greater than that of NBD-chol.
Comparison of the half-times of DHE and NBD-chol uptake also revealed
significant differences. The half-time of DHE uptake by L-cells is
about 1 day (12), similar to that for [3H]cholesterol
(39). In contrast, the half-time of NBD-chol uptake was much faster, 6 min (see below). Therefore, the half-time of DHE uptake was >100-fold
slower than that of NBD-chol.
Finally, the intracellular esterification of DHE and NBD-chol by L-cell
fibroblasts differed much less than observed for uptake and half-time
of uptake. HPLC of lipid extracts from L-cells supplemented with DHE
showed two peaks, near 3 min (DHE-ester) and 19 min (DHE), respectively
(Fig. 1A). When the cells were
cultured with 5 and 15 µg of DHE/ml medium, 5.2 ± 0.5%
(n = 5) (not shown) and 27.6 ± 9.0%
(n = 4) (Fig. 1C) of the DHE taken up was
esterified, respectively. This was 1.4-fold (not shown) and 7.5-fold
(Fig. 1C), respectively, more than that of
[3H]cholesterol (Fig. 1C). The same HPLC
system also resolved lipid extracts from NBD-chol (5 µg of
NBD-chol/ml of medium) supplemented L-cells into two peaks with
retention times near 5 min (NBD-chol ester) and 17 min (NBD-chol) (Fig.
1B). The NBD-chol ester represented only 7.8 ± 0.4%
(n = 5) of total NBD-chol taken up (Fig.
2C), only 2-fold more than
that of [3H]cholesterol (Fig. 1C). Thus, under
the conditions necessary for obtaining optimal fluorescence images and
energy transfer (see below), DHE was esterified 3.5-fold more than
NBD-chol.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 1.
Intracellular esterification of sterols in
cultured L-cell fibroblasts. DHE, NBD-cholesterol, and
[3H]cholesterol were individually incorporated into
L-cells as described under "Experimental Procedures." Lipids were
extracted from L-cells after 24 h incubation in complete medium as
described under "Experimental Procedures." Panel A, high
performance liquid chromatogram of DHE detected by absorbance at 324 nm. Panel B, high performance liquid chromatogram of
NBD-chol detected by absorbance at 443 nm. Panel C, extent
of esterification of [3H]cholesterol, NBD-cholesterol,
and DHE after 24 h incubation. Values represent mean ± S.E.
from four to five experiments.
|
|

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 2.
Multiphoton excitation fluorescence imaging
of DHE and NBD-cholesterol in intact L-cell fibroblasts.
A, three-photon excitation DHE fluorescence in L-cells.
Cells were preincubated with 12 µg/ml DHE for 24 h in serum
containing medium as described under "Experimental Procedures."
Excitation wavelength 930 nm. B, two-photon excitation
NBD-cholesterol fluorescence in a separate set of L-cells. Cells were
preincubated with 5 µg/ml NBD-cholesterol for 24 h in serum
containing medium. Following incubation with fluorescent probes, cells
were washed three times with phosphate-buffered saline to remove
unbound probe and transferred into the Puck's buffer, pH 7.4. The
images were obtained at room temperature. For more details see
"Experimental Procedures."
|
|
In summary, both DHE and NBD-chol were taken up by L-cell fibroblasts
and esterified intracellularly. In contrast to the 2 order of magnitude
differences in uptake parameters, however, the two fluorescent sterols
differed much less in proportion esterified, especially when cultured
in the presence of equimolar DHE or NBD-chol (5.2% versus
7.8% esterified). This suggested that while DHE and NBD-chol uptake
may differ, once internalized both sterols appeared to share a similar
intracellular esterification pathway and, as shown below, similar
intracellular targeting.
The Intracellular Distribution of DHE in L-cell Fibroblasts:
Multiphoton Laser Scanning Microscopy--
As indicated in the
Introduction, the UV excitation (maximum near 320 nm) required for DHE
excitation resulted in high photobleaching of DHE. This drawback
coupled with potential phototoxicity of exposing living cells
containing DHE to high energy UV radiation for extended periods of
time, seriously complicated the use of LSCM or conventional
fluorescence microscopy for visualizing the intracellular distribution
of DHE. Fortunately, these drawbacks of UV excitation can be
circumvented by multiphoton infrared excitation and MLSM (40, 41).
Although two-photon excitation and MLSM of DHE in L-cells allowed
detection of DHE, this was complicated by simultaneous
autofluorescence. At the lower wavelength limit of the Ti/Sa laser
(about 680-700 nm) two-photon excitation of DHE simultaneously excited
endogenous NADH resulting in high autofluorescence in the L-cells (data
not shown).
In contrast, three-photon excitation conditions allowed selection of
excitation wavelength at which no detectable autofluorescence was
observed by MLSM. DHE excitation equivalent to about 310 nm was
achieved by combining the energy of three infrared photons with 930 nm
wavelength. Under three-photon conditions these photons were
simultaneously absorbed by the DHE chromophore which subsequently displayed stable emission. Three-photon MLSM of DHE in L-cells detected
DHE inside the cells, highly localized in large punctate areas with
additional diffuse emission (Fig. 2A). This pattern of DHE
distribution to large punctate areas resembled that of lipid droplets
visible by transmission microscopy (Fig.
3A).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 3.
Intracellular localization of NBD-cholesterol
in L-cells dually labeled with NBD-cholesterol and Nile Red.
A, transmitted light image obtained with a Bio-Rad MRC-1024
laser scanning fluorescence microscope using the transmitted light
detector mode. The transmitted light image showed the outline and
overall morphology of the cell. Visible are the highly refractile lipid
droplets. B, single-photon excitation LSCM Image of
NBD-cholesterol. C, single-photon excitation LSCM Image of
Nile Red. D, sequentially acquired images B and C were
superimposed to yield a merged image. Colocalized NBD-chol and Nile Red
appeared as yellow-orange punctate structures. E,
pixel fluorogram of the merged image showing the high degree of
NBD-chol and Nile Red fluorescence spatial correlation in L-cells.
NBD-cholesterol was excited with the 488-nm laser line and fluorescence
emission detected with a 530/20 band pass filter. Nile Red was excited
with 568 nm laser line and emission detected with a 680/30 band pass
filter. For more details see "Experimental Procedures."
|
|
Multiphoton Laser Scanning Microscopy of NBD-cholesterol in L-cell
Fibroblasts--
It is not known whether NBD-chol (a synthetic sterol
with NBD group attached in the acyl chain of cholesterol) exhibits a similar intracellular distribution as DHE, a naturally occurring sterol
that codistributes with cholesterol (see Introduction) in L-cells. To
examine the intracellular distribution of NBD-chol, the fluorescent
sterol was incorporated into L-cells exactly as described for DHE
except that two-photon excitation at 930 nm was used. The simultaneous
absorption of two-photons at 930 nm was equivalent to single photon
excitation at 465 nm, a wavelength at which NBD-chol efficiently
absorbs while autofluorescence was negligible (not shown). MLSM of
NBD-chol in L-cells displayed a very similar punctate intracellular
fluorescence pattern (Fig. 2B) as was observed by MLSM of
DHE (Fig. 2A) in L-cells. The pattern of NBD-chol
distribution (Fig. 2B) also resembled that of lipid droplets
visible by transmission microscopy (Fig. 3A).
Colocalization of NBD-cholesterol to Lipid Droplets in Intact
L-cell Fibroblasts by LSCM--
In order to determine if the
fluorescent sterol probes were present in lipid droplets,
colocalization experiments were performed with Nile Red, a neutral
lipid specific probe known to stain lipid droplets (42, 43).
Unfortunately, because of the photophysics of three-photon excitation,
the low quantum yield of DHE, and the instrumental limitations, the
emission of DHE was too weak for simultaneous colocalization with Nile Red.
In contrast to DHE, the spectral properties of NBD-chol were ideal for
single-photon excitation and imaging by LSCM in order to establish
whether the punctate distribution of NBD-chol observed above was due to
its presence in lipid droplets. Therefore, L-cells were dually labeled
with NBD-chol and Nile Red as described under "Experimental
Procedures" and imaged by LSCM (Fig. 3). The red colored
intracellular punctate structures obtained with Nile Red (Fig.
3C) were clearly visible on the transmitted light image (Fig. 3A) and appeared almost identical with the
intracellular distribution pattern of the green punctate structures
detected by NBD-cholesterol acquired simultaneously in L-cells (Fig.
3B). Colocalization of the Nile Red and NBD-chol would be
visualized as a merging of red and green to yield a orange-yellow
punctate distribution. Indeed, a merged image of Nile Red and NBD-chol (Fig. 3D) revealed a distinctly orange-yellow punctate
distribution. The respective fluorogram (Fig. 3E)
constructed from the merged image further confirmed the high degree of
the fluorescence spatial colocalization of these probes. The size of
the lipid droplets revealed by colocalization of NBD-chol (Fig.
3B) and Nile Red (Fig. 3C) as well as by
transmission microscopy (Fig. 3A) ranged from 0.3-0.5 µm.
In summary, NBD-chol was taken up by L-cells and targeted to lipid droplets.
Proximity of DHE and NBD-cholesterol in Dual-labeled L-cell
Fibroblasts as Probed by FRET--
Although NBD-chol was highly
colocalized within large punctate structures identified as lipid
droplets (Nile Red) and DHE also distributed to similar punctate
structures in L-cells, the spatial resolution of light microscopy is
only 0.3 µm. To achieve Å level resolution necessary to determine
the intermolecular distance between NBD-chol and DHE within the lipidic
structures, it was necessary to use FRET. The fluorescence emission
spectrum of the donor (DHE) overlapped significantly with the
absorption spectrum of the acceptor (NBD-chol) (not shown), a primary
criterion necessary for efficient FRET (33).
The FRET from DHE to NBD-chol in L-cells was examined by MLSM. L-cells
were dual labeled with (15 µg of DHE + 5 µg of NBD-chol)/ml medium
and excited at 930 nm. Under these conditions (simultaneous three-photon excitation of DHE and two-photon excitation of NBD-chol) the level of the DHE emission (but not NBD-chol) in lipid droplet structures of L-cells was qualitatively lower (data not shown). Unfortunately, the low intensity of the DHE emission in these images
did not allow accurate determination of R, the
intermolecular distance between DHE and NBD-chol.
To obtain quantitative data for determining R, FRET between
DHE and NBD-chol was determined with L-cells in suspension by use of a
very sensitive photon counting fluorometer. Again, L-cells were
cultured in 10% FBS medium with or without DHE, NBD-chol as described
above. Following incubation, the cells were washed and fluorescence
excitation spectra were obtained as described in the legend of Fig.
4. The excitation spectrum (detected at the NBD-cholesterol emission maximum, em = 550 nm) of
L-cells labeled only with NBD-chol (Fig. 4) revealed a small excitation maximum near 330 nm and a major excitation maximum at 460 nm. In
contrast, the excitation spectrum (detected at the NBD-cholesterol emission maximum, em = 550 nm) of L-cells labeled only
with DHE exhibited only an excitation maximum near 325 nm and no
excitation maximum near 460 nm (Fig. 4). However, the excitation
spectrum of the dual-labeled cells (detected at the NBD-cholesterol
emission maximum, em = 550 nm) displayed a strong
excitation maximum at ~325 nm and a 2-fold weaker excitation maximum
at ~460 nm. Under the same experimental conditions, the non-labeled
cells exhibited no detectable fluorescence signal. The data obtained
indicated that in the dual-labeled cells, NBD-cholesterol solely
contributed to the observed excitation maximum at ~460 nm, while the
excitation fluorescence band at ~325 nm was predominantly due to DHE.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 4.
Fluorescence energy transfer between DHE and
NBD-cholesterol in L-cell fibroblasts. Representative spectra
(viewed from top to bottom at 325 nm) were as
follows. Solid line was the fluorescence excitation spectrum
of the cells dually labeled with DHE (15 µg/ml) and NBD-cholesterol
(5 µg/ml) in serum containing medium as described under
"Experimental Procedures." Dash-dot line was the
combined fluorescence excitation spectra of the single fluorescent
sterol (DHE or NBD-chol) labeled cells. Dashed line was the
fluorescence excitation spectrum of L-cells labeled with 5 µg/ml DHE.
Dotted line was the fluorescence excitation spectrum of
L-cells labeled with NBD-cholesterol (5 µg/ml). Combined spectra were
obtained as follows. The DHE and NBD-cholesterol fluorescence
excitation spectra in the single-labeled cells were corrected according
to the DHE and NBD-cholesterol concentration in the dual-labeled cells,
added together, and normalized to the intensity at 460 nm. Fluorescence
was detected at 550 nm. For more details, see "Experimental
Procedures" and the text. At the end of the incubation cycle, cells
were washed three times with phosphate-buffered saline to remove the
unbound probe, trypsinized, and centrifuged. Following centrifugation,
cells were resuspended in the Puck's buffer, counted, diluted to
2 × 105 cells/ml, and transferred into a photon
counting spectrofluorimeter or spectrophotometer for the spectral
analysis as described under "Experimental Procedures."
|
|
If FRET occurred from DHE to NBD-cholesterol in the dual-labeled cells,
the DHE excitation band intensity at ~325 nm (while detecting
predominantly NBD-cholesterol emission at 550 nm) was expected to
increase. This possibility was examined as follows. (i) The DHE and
NBD-cholesterol excitation fluorescence spectra acquired separately in
the single-labeled cells were corrected for the difference in DHE and
NBD-cholesterol concentration in the dual-labeled cells (Fig. 4,
bottom two curves). (ii) The intracellular probe
concentration was measured in the same samples by the means of
absorption spectroscopy. (iii) The corrected single DHE and NBD-cholesterol spectra were added together and normalized to the
intensity of NBD-cholesterol band at ~460 nm (Fig. 4, second curve from the top). This allowed construction of the
mathematically combined curve obtained under conditions of no energy
transfer, i.e. from cells labeled separately with NBD-chol
or DHE, but not both (Fig. 4, second curve from the
top). Comparison to the curve for dual-labeled cells (both
DHE and NBD-chol) also normalized to the intensity at ~460 nm
(Fig. 4, top curve), clearly demonstrated that the intensity
of the NBD-cholesterol excitation at ~325 nm was indeed increased in
the dual-labeled cells as compared with a mathematical combination from
cells loaded separately with DHE or NBD-cholesterol. This allowed
calculation of the critical energy transfer distance
R0 = 25.8 Å. From these data and using a
R0 = 25.8 Å (see "Experimental
Procedures"), the average distance R between DHE and
NBD-chol in the dual-labeled cells (Equation 3) was estimated to be 26 Å.
It must be considered that the average distance R between
DHE and NBD-chol, 26 Å, may reflect contributions from both the unesterified and esterified fluorescent sterols. This possibility was
based on the fact that 27.6% and 8% of DHE and NBD-chol were esterified, respectively (Fig. 1), under the conditions used for FRET.
The relative contributions of the esterified fluorescent sterols may be
evaluated based on the structure of lipid droplets which is basically a
nonpolar lipid core (sterol esters and triacylglycerols) surrounded by
a more polar surface polar monolayer (sterols and phospholipids) (44,
45). The nonpolar core of L-cell lipid droplets is cholesterol
ester-rich (cholesterol ester/triacylglycerol ratio of 30:1) (46),
typical of lipid droplets in tissues such as adrenal (cholesterol
ester/triacylglycerol ratio of 8:1) (44). This suggests three possible
types of FRET. (i) From DHE donor to NBD-chol acceptor in the lipid
droplet polar monolayer. Since the majority (93%) of NBD-chol was not
esterified and unesterified sterols readily phase separate into
sterol-rich domains (2), conditions were favorable for FRET between DHE
and NBD-chol in the lipid droplet monolayer. (ii) From DHE-ester donor
to NBD-chol ester acceptor in the lipid droplet nonpolar core. The
orientation factor between these sterol esters in the core was not as
favorable as that in the surface monolayer due to the more random
orientation as well as higher fluidity of the neutral lipid core (10,
11). These factors, along with the several order of magnitude greater volume of dilution of the lipid core, did not favor FRET. (iii) From
DHE donor in the lipid droplet surface monolayer and NBD-chol ester
acceptor in the core of the lipid droplet. The diameter of the L-cell
lipid droplets was 3000-5000 Å, while the thickness of a polar lipid
monolayer was much smaller, 25 Å. Because of this 120-200-fold
greater thickness of the neutral lipid core, the majority of NBD-chol
ester acceptor was not likely near the DHE donor in the surface
monolayer. The higher fluidity of the neutral lipid core also yielded a
less favorable orientation factor for energy transfer. These
considerations, taken together with energy transfer varying as
R 6, resulted in much lower efficiency of
energy transfer from the surface monolayer to the core than within the
surface monolayer (10, 11).
In summary, FRET revealed the average intermolecular distance between
DHE and NBD-chol to be 26 Å, >100-fold closer than that resolvable by
optical microscopy. The 26-Å intermolecular distance was easily
encompassed within the lipid droplets whose diameter (range from 0.3 to
0.5 µm, see above) was 120-200-fold greater. Finally, the
cross-sectional diameter of cholesterol, about 13 Å, suggests that on
average the DHE and NBD-chol were separated by no more than the
thickness of another lipid molecule, regardless of whether these
fluorescent sterols were esterified or whether they were located in the
lipid droplet surface or interior core.
Uptake kinetics of NBD-cholesterol into L-cell Fibroblasts: a LSCM
Investigation--
NBD-chol allows direct visualization of the uptake
of unesterified sterol into living cells. In the absence of serum the
uptake of NBD-chol into the L-cells was very slow, as shown by the
cellular fluorescence near baseline and half-time to reach maximum
cellular fluorescence >85 min (Fig.
5A, solid circles). Serum
markedly enhanced NBD-chol uptake (t1/2 = 6.1 ± 0.8 min, maximum near 10 min). In the presence of serum, NBD-chol
uptake exhibited sigmoidal kinetics (Fig. 5A, solid squares) as well concentration dependence up to 0.5 µg/ml and approached saturation (Fig. 5A). However,
saturation was still not complete even at the highest NBD-chol
concentration (3 µg/ml). The Hill coefficient (b ~ 2.6) of serum
mediated NBD-chol uptake was independent of NBD-chol concentration
(data not shown), consistent with a multicomponent uptake. In contrast,
the half-time of NBD-chol uptake into L-cells decreased by almost
5-fold, from 6.1 ± 0.8 min to minimum near 1.3 ± 0.6 min,
over a 15-fold increase in NBD-cholesterol concentration in the medium
(data not shown).

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 5.
Kinetics of unesterified cholesterol influx
in L-cell fibroblasts in the presence of lipid vehicles.
A, NBD-chol uptake kinetics shown as average fluorescence
pixel intensity per cell. Closed squares, medium containing
5% fetal bovine serum; open squares, serum-free medium + 17 µg/ml HDL; closed triangles, serum-free medium + 50 µM BSA; closed circles, serum-free medium. The
half-time of NBD-chol uptake in serum-free medium alone could not be
accurately measured. However, extrapolation of the baseline suggested a
half-time >85 min. B, transmitted light image of L-cells
monolayer; C-E, single-photon excitation LSCM images of
NBD-cholesterol fluorescence in L-cells (5% fetal bovine serum) 30, 60, and 120 s after addition of 0.5 µg/ml NBD-cholesterol. The
bright staining intracellular structures were lipid droplets. The
digitized fluorescence signal was corrected for the background measured
outside the cells. The background fluorescence was <0.5% of the
maximal NBD-cholesterol signal in all cases studied. At least three
independent series of experiments were performed and representative
curves are shown. For more details, see "Experimental
Procedures."
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 6.
Kinetic parameters of NBD-cholesterol influx
in L-cell fibroblasts. All parameters of NBD-chol uptake were
measured in serum-free medium supplemented with the indicated
concentration of HDL. The maximal fluorescence intensity
(A), the Hill coefficient (B), and the half-time
parameters (C) were obtained from the respective kinetics as
described under "Results." NBD-cholesterol concentration was 0.5 µg/ml. Abscissa, HDL concentration, µg/ml. All
experiments were performed at 25 °C. Data are mean ± S.E.
(n = 14-79).
|
|
Uptake Kinetics of NBD-cholesterol into Specific Intracellular
sites in L-cell Fibroblasts: Targeting to Lipid Droplets as Determined
by LSCM--
In the absence of serum, NBD-chol uptake into lipid
droplets was essentially not detectable over the 10-min time period
examined (not shown). In contrast, in the presence of serum NBD-chol
was detected in lipid droplets within 30 s (Fig.
5C), followed by its gradual increase in the cytoplasmic
area (60 and 120 s, Fig. 5, D and E). Uptake
of NBD-chol into lipid droplets was very fast (t1/2 = 5.8 ± 0.7 min) and essentially the same as that observed into
the whole cell (t1/2 = 6.1 ± 0.8 min). Thus,
NBD-chol was extremely rapidly, <30 s, transferred from the cell
surface to lipid droplets in L-cells.
Specific Components of Serum Mediating Rapid Uptake of Unesterified
Cholesterol in L-cell Fibroblasts as Determined by
NBD-chol--
Albumin only weakly stimulated NBD-chol uptake as
compared with serum with onset near 3 min (>3-fold longer than with
serum), and extrapolated time to achieve maximum uptake of hours (Fig. 5A, solid triangles). In contrast, HDL (17 µg/ml)
dramatically stimulated NBD-chol uptake with onset <30 s (Fig.
5A, open squares) and t1/2 = 2.6 ± 0.7 min which was 60% shorter than of serum, t1/2 = 6.1 ± 0.8 min (Fig. 5A, open versus closed
squares). In contrast, the other serum lipoproteins (17 µg/ml)
were less effective: LDL, t1/2 = 5-7 min; VLDL,
t1/2 = 11 min. Furthermore, while HDL and LDL
mediated NBD-chol uptake fit the Hill's equation, VLDL mediated
NBD-chol uptake did not. However, in all cases intracellular targeting
of NBD-chol was to lipid droplets. In summary, NBD-chol detected the
existence of a fast, lipoprotein-dependent (HDL > LDL > VLDL) mechanism(s) for uptake and targeting of unesterified
sterol to lipid droplets. Since LDL and VLDL interact within endocytic
uptake (LDL receptor, VLDL receptor) as well as non-endocytic uptake
(HDL receptors), but do not effectively compete with HDL for binding to
the HDL receptor (reviewed in Ref. 4), NBD-chol uptake was the average of both processes. Since HDL does not bind to the LDL receptor, this
allows select examination of the uptake kinetics of unesterified cholesterol via the HDL receptor pathway alone.
Concentration Dependence and Kinetic Analysis of HDL-mediated
NBD-chol Uptake in L-cell Fibroblasts--
The HDL-dose dependence of
the unesterified sterol uptake was studied at an NBD-chol (0.5 µg/ml)
concentration far from saturating intracellular NBD-cholesterol
fluorescence. The maximal fluorescence of NBD-chol uptake in L-cells
was independent of HDL concentration from 0 to 34 µg/ml (Fig.
6A), essentially the same as that in serum-containing medium
(Fig. 5A). The Hill coefficient of NBD-chol uptake decreased
3-fold between 4 and 34 µg of HDL/ml (Fig. 6B) to resemble
than in serum containing medium. The t1/2 of
NBD-chol uptake decreased 42-fold from 0 to 34 µg of HDL/ml (Fig.
6C), >3-fold faster than that in serum-containing medium. Interestingly, at higher concentrations of LDL or VLDL these
lipoproteins had the opposite effect on t1/2 of NBD-chol uptake and actually increased the half-time of NBD-chol uptake
2-3-fold (data not shown). Thus, increasing LDL or VLDL (but not HDL)
slowed NBD-chol uptake, reflecting increasing contributions of the
slower endocytic processes mediated via LDL and VLDL receptors. When the medium HDL concentration was held constant (17 µg/ml) and
the NBD-chol concentration was increased from 0.2 to 1 µg/ml the
half-time of HDL-mediated NBD-chol uptake significantly decreased almost 5-fold, from 7.3 ± 1.2 min to 1.3 ± 0.4 min
(n = 14-79). Thus, at higher concentrations the HDL
enhanced more rapid HDL receptor mediated uptake of unesterified
sterol while higher LDL or VLDL concentrations enhanced the slower
endocytic uptake of unesterified cholesterol.
Examining the Molecular Basis of HDL-mediated Unesterified
Cholesterol Uptake in L-cells--
HDL-mediated cholesterol uptake is
mediated through caveolae, cholesterol-rich plasma membrane surface
microdomains, rich in caveolin-1 and SRB1 (3, 4). Western blotting of
L-cell fibroblasts detected both caveolin-1 and SRB1 (data not shown). Indirect immunofluorescence and LSCM showed that caveolin-1 was localized in the cell surface (Fig.
7A) and in an intracellular pool (Fig. 7B), consistent with the literature showing
caveolin-1 in plasma membrane caveolae, in Golgi/endoplasmic reticulum,
and in a soluble complex (4). Indirect immunofluorescence identified two pools of SRB1, a surface associated pool (Fig. 7C) as
well as a cytoplasmic pool (Fig. 7D), consistent with the
literature (4). Pretreatment of L-cells for 30 min with filipin (2 and 10 µg/ml, respectively), which specifically inhibits HDL-mediated sterol uptake via caveolae but LDL receptor mediated uptake via clathrin coated pits (47, 48), increased the t1/2 for HDL-mediated NBD-chol uptake 2.2- and 2.7-fold, respectively, from
102 ± 20 to 228 ± 17 and 272 ± 24 s
(n = 3).

View larger version (81K):
[in this window]
[in a new window]
|
Fig. 7.
Indirect immunofluorescence of caveolin-1
(A and B) and scavenger receptor type
B-I (C and D) in L-cells.
Optical sections were taken from Z-scan single-photon excitation LSCM
images at 6 µm (A and C) and 9 µm
(B and D) from the bottom of the chambered slide.
The fluorescence emission of the caveolin-1 and SRB-I secondary
antibodies labeled with Alexa 594 was obtained after excitation with
568 nm laser line and emission selected with a combination of 640LP and
680/30 band pass filters.
|
|
Molecular Basis for Targeting of Unesterified Sterol to Lipid
Droplets--
The molecular basis for unesterified sterol targeting to
lipid droplets is not known. Very little is known whether the
unesterified sterol in lipid droplets (44) is primarily present within
the lipid phase or whether it is protein associated. The FRET data (see
above), showing an intermolecular distance near 26 Å, suggested that
unesterified sterols were present in the lipid phase, but did not
exclude specific binding to protein in the lipid droplet. The best
known lipid droplet protein, ADRP is localized to lipid droplets (43,
49), binds hydrophobic lipids such as NBD-stearic acid in 1:1
stoichiometry (50),2 and increases fatty acid uptake (50).
Therefore, the possibility that ADRP also binds unesterified sterol and
is present in L-cell lipid droplets was examined.
The ability of ADRP to bind unesterified sterol was determined with
mouse recombinant ADRP and a fluorescence sterol binding assay. The
interaction of ADRP with NBD-chol was monitored as an increased
fluorescence intensity and a blue shift in the NBD-chol emission
maximum from 545 to 530 nm (Fig.
8A). ADRP exhibited saturation
binding of NBD-chol (Fig. 8B). Analysis of the binding data
showed that ADRP bound NBD-chol with high affinity,
Kd = 2.0 nM, and 1:1 molecular
stoichiometry. ADRP bound NBD-chol was effectively displaced by
cholesterol, KI = 13 nM (Fig.
8C), but not by ligands such as oleic acid and oleoyl-CoA (data not shown).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 8.
Sterol binding to ADRP. Panel
A, fluorescence emission spectra of NBD-chol without (curve
1) or with (curves 2-4) 70 nM ADRP in 25 mM phosphate buffer. NBD-chol was excited at 473 nm. From
bottom to top, the NBD-chol concentrations were
25 nM (curves 1 and 2), 75 nM (curve 3) and 100 nM (curve
4). Panel B, saturation binding of NBD-chol (0 to 100 nM) to ADRP (11.1 nM). The intensities
represent the maximal fluorescence intensity values are from a
representative of four independent experiments. The data were fit to a
simple, single binding site model as described under "Experimental
Procedures." Panel C, displacement of ADRP bound NBD-chol
by cholesterol. ADRP (70 nM) was preincubated with
NBD-cholesterol (7 nM), followed by addition of displacing
cholesterol (from 1.5 to 46.5 nM).
|
|
L-cells contained significant amounts of ADRP as revealed by Western
blotting. L-cells expressed ADRP at a level intermediate with that of
differentiated and undifferentiated 3T3 adipocytes (data not shown). As
compared with the fibroblast-like, undifferentiated adipocytes, the
expression of ADRP in L-cells was 4-fold higher. However, as compared
with differentiated adipocytes, the expression of ADRP in L-cells was
nearly 13-fold lower. Thus, ADRP expression in L-cells was within the
range of cells accumulating lipid droplets.
Indirect immunofluorescence imaging revealed that ADRP was localized to
lipid droplets in L-cells. Furthermore, ADRP colocalized with NBD-chol
(Fig. 9) which in turn colocalized with
Nile Red in lipid droplets of L-cells (Fig. 3). Single photon
excitation LSCM with simultaneous acquisition of images for ADRP and
NBD-chol showed a pattern of ADRP distribution (green) and NBD-chol
distribution (red) that was very similar in L-cells (Fig. 9,
A and B, respectively). Superposition of the
simultaneously acquired images revealed a high degree of colocalization
as shown by orange/yellow structures (Fig. 9C). The
colocalization of ADRP with NBD-chol in lipid droplets in L-cells was
quantitatively confirmed by the pixel fluorogram (Fig. 9D).
In the pixel fluorogram most of the points were located away from the
x and y axes. No colocalization would have been observed as two separate populations of points lying near the respective x and y axes. Finally, the
insets in Fig. 9 show a magnification of a representative
lipid droplet. A comparison of the NBD-chol staining of this lipid
droplet (Fig. 9A, inset) with that of ADRP staining (Fig.
9B, inset) suggested that the diameter of the ADRP staining
extended beyond that of the NBD-chol staining. To further validate this
observation, the images of the lipid droplet in the insets of Fig. 9,
A and B, were merged (Fig. 9C, inset).
In the merged lipid droplet image (Fig. 9C, inset), the ADRP
not colocalized with NBD-chol extended as a red ring or border beyond
that of ADRP colocalized with NBD-chol shown as a yellow center in the
lipid droplet. These data suggest that ADRP interacted both with the
lipid phase as well as ADRP molecules extending beyond the lipid
droplet surface. The relative proportion of NBD-chol associated with
the lipid phase versus ADRP was evidenced by the
preponderance of yellow pixels (ADRP associated NBD-chol) and only a
small amount of green pixels (NBD-chol in the lipid phase not
colocalized with ADRP).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 9.
Indirect immunofluorescence of ADRP and
NBD-Chol. All procedures were as described under "Experimental
Procedures." A, ADRP. B, NBD-chol.
C, superimposed A and B to obtain a merged image.
Colocalization is shown as yellow-green. D, pixel
fluorogram showing high degree of colocalization of ADRP and NBD-chol.
The insets in the figure, represent a typical lipid droplet
in the dual labeled cells.
|
|
Thus, ADRP was expressed in L-cells and localized to the surface of the
lipid droplets. This location in conjunction with its high affinity for
sterol (Fig. 8) suggested that the presence of ADRP at the surface of
the lipid droplet could account, at least in part, for the high degree
of targeting of fluorescent sterols such as NBD-chol and DHE to lipid
droplets in L-cells.
 |
DISCUSSION |
Although LDL receptor-mediated lipid metabolism has been
characterized in depth over the past two decades, much less is known regarding the role of HDL in unesterified cholesterol dynamics, especially in living cells (for review, see Refs. 5, 51, and 52). In
contrast to LDL receptor-mediated lipid uptake, this "alternate"
pathway utilizes a completely different receptor (SRB1 receptor instead
of LDL receptor), has a different apoprotein specificity (binds HDL as
well as LDL and VLDL), is mediated through a different plasma membrane
microdomain (caveolae instead of clathrin-coated pits), does not
internalize (endocytose) whole lipoprotein particles, and takes up
lipids in the order: cholesterol esters phosphatidylserine > phosphatidylcholine = phosphatidylinositol > sphingomyelin (53). Although HDL mediates cholesterol ester uptake in
nonplacental steroidogenic tissues as well as cultured cells (for
review, see Refs. 4 and 54) only recently was this visualized with
fluorescent sterol ester (55). In contrast, while it is generally
accepted that HDL mediates rapid efflux of cellular unesterified
cholesterol, a process termed "reverse cholesterol transport," very
little is actually known of HDLs role in uptake and intracellular
targeting of unesterified cholesterol, especially in living cells (for
review, see Refs. 5 and 54). The results of the present investigation provided several new insights on HDL-mediated uptake on unesterified sterol uptake.
First, comparison of the extent as well as t1/2 of
uptake for the fluorescent sterols, DHE and NBD-chol, to that of
[3H]cholesterol suggested that the two fluorescent
sterols may selectively probe different uptake pathways. Although the
uptake and half-time for maximal uptake of the fluorescent DHE
resembled that of [3H]cholesterol, NBD-chol uptake was
>100-fold more rapid, but >100-fold less efficient. Recent data
showed that NBD-chol uptake and flux through hamster intestine as well
as NBD-chol uptake in Caco-2 cells is also markedly faster than that of
radiolabeled cholesterol (24). Although it was suggested that these
differences are due to lower affinity of NBD-chol for a cholesterol
transporter or decreased solubility of NBD-chol, the present data
suggested otherwise. NBD-chol has very high affinity (nM)
for lipid-binding proteins such as ADRP (present data) and sterol
carrier protein-2 (16, 56). Likewise, the critical micellar
concentration of NBD-chol differs only 2-fold from that of DHE and
cholesterol (27, 57). The two major receptor-mediated sterol transport
pathways differ markedly in speed: slow (15-45 min) LDL
receptor-mediated (endocytic) uptake (for review, see Ref. 52);
fast (1 min) HDL receptor-mediated efflux of cholesterol (for review,
see Ref. 4). These data, taken together with the lipoprotein (HDL
versus LDL and VLDL) specificity of NBD-chol uptake shown
herein and earlier for esterified cholesterol (for review, see Refs. 5,
53-55, and 58) as well as the effects of filipin on NBD-chol uptake
shown herein and on cholesterol ester uptake elsewhere (for review, see
Refs. 47, 48, and 55) were consistent with the uptake of the two
fluorescent, unesterified sterols being mediated, at least in part, by
different mechanism(s).
Second, once internalized the DHE and NBD-chol appear to follow similar
pathways to be esterified as compared with
[3H]cholesterol. At equimolar concentrations these
sterols differed less than <2-fold in esterification. L-cell
esterification of DHE confirms an earlier study (2) while that of
NBD-chol clarifies a controversy in the literature (see Introduction).
NBD-chol is esterified in vivo by hamster intestine and
Caco-2 cells, derived from intestine, as well as in vitro by
intestinal microsomes (24). In contrast, rat liver microsomes did not
esterify NBD-chol (25). The different observations may be due to
differences in the substrate specificities of the two known acyl-CoA
cholesterol acyltransferases (1 or 2). Acyl-CoA:cholesterol
O-acyltransferase 1 is absent from intestinal cells while
liver contains both acyl-CoA:cholesterol O-acyltransferase 1 and 2 (59).
Third, once internalized the fluorescent sterols rapidly target to
lipid droplets. LSCM and MLSM imaging, colocalization with Nile Red,
and FRET all indicated specific targeting of the HDL-mediated unesterified sterol uptake to lipid droplets. This process was specific
for the HDL-mediated uptake of unesterified (shown herein) and
esterified sterols, but not DiI (55). The speed (<30 s) of
HDL-mediated NBD-chol targeting to lipid droplets was much faster than
that of HDL-mediated uptake of BODIPY-cholesterol ester, 5 min (55).
However, this very rapid (<30 s) intracellular transfer of
unesterified NBD-chol was similar to that of endogenously synthesized
cholesterol from the endoplasmic reticulum to the cell surface, 1 min
(for review, see Ref. 4), and implied a nonvesicular pathway(s).
Several candidate intracellular cholesterol-binding proteins (sterol
carrier protein-2, caveolin-1, steroidogenic acute regulatory protein,
etc.) for such a nonvesicular mechanism have been proposed (for review,
see Refs. 4 and 16).
Fourth, the specific targeting of unesterified cholesterol to lipid
droplets may be mediated, at least in part by ADRP, a lipid droplet
specific protein (49). ADRP in L-cells was localized on the surface of
lipid droplets as in other cell types (43). More important, indirect
immunofluorescence revealed that the ADRP was highly colocalized with
NBD-chol in the lipid droplet. Finally, ADRP specifically bound
NBD-chol with high affinity (Kd = 2 nM),
suggesting that this colocalization was due at least in part to direct
binding of NBD-chol ADRP. This affinity was in the same range of
that of other known sterol-binding proteins, e.g. sterol
carrier protein-2 with Kd = 6-11 nM
(16, 57). Since ADRP has been shown to also bind fatty acid
(50),2 this would indicate that ADRP can bind several types
of lipid substrates, similar to sterol carrier protein-2 (30, 56, 57, 60-62).
In summary, the data presented herein were consistent with DHE and
NBD-chol uptake preferentially taking place by different pathways,
e.g. LDL receptor endocytic versus HDL receptor
molecular transfer via caveolae. Furthermore, both DHE and NBD-chol
demonstrated specific targeting of unesterified sterol to lipid
droplets, a process that was very rapid and potentially mediated by
ADRP, a lipid-binding protein specific to droplets. Thus, these data provided basic new observations contributing to our understanding of
HDL receptor-mediated uptake of unesterified cholesterol, its intracellular dynamics, and its targeting to lipid droplets, an organelle about which very little is known (43, 45, 49).
 |
FOOTNOTES |
*
This work was supported in part by United States Public
Health Service, National Institutes of Health Grants GM 31561 (to F. S.), 5P41RR03155 (to E. G.), and DK41463 and American
Heart Association Grant 9951222U (to G. S.). These data were
presented in part at the 43rd Annual Meeting of the
Biophysical Society (Frolov, A., Petrescu, A., Atshaves, B. P.,
So, P. T. C., Gratton, E., Serrero, G., and Schroeder, F. (1999) Biophys. J. 76, A99, poster 397).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel: 409-862-1433;
Fax: 409-862-4929; E-mail: fschroeder@cvm.tamu.edu.
2
G. Serrero, A. Frolov, F. Schroeder, and L. Gelhaar, submitted for publication.
 |
ABBREVIATIONS |
The abbreviations used are:
LDL, low density
lipoprotein;
HDL, high density lipoprotein;
VLDL, very low density
lipoprotein;
SR-BI, scavenger receptor BI;
DHE, dehydroergosterol;
NBD-chol, NBD-cholesterol,
22-(N-7-nitrobenz-2-oxa-1,3-diazo-4-yl)-amino-23,24-bisnor-5-cholen-3 -ol));
FRET, fluorescence resonance energy transfer;
MLSM, multiphoton laser
scanning microscopy;
LSCM, laser scanning confocal microscopy;
ADRP, adipose differentiation-related protein;
FBS, fetal bovine serum;
HPLC, high performance liquid chromatography;
BSA, bovine serum
albumin.
 |
REFERENCES |
| 1.
|
Schroeder, F.,
Woodford, J. K.,
Kavecansky, J.,
Wood, W. G.,
and Joiner, C.
(1995)
Mol. Membr. Biol.
12,
113-119[Medline]
[Order article via Infotrieve]
|
| 2.
|
Schroeder, F.,
Frolov, A. A.,
Murphy, E. J.,
Atshaves, B. P.,
Jefferson, J. R.,
Pu, L.,
Wood, W. G.,
Foxworth, W. B.,
and Kier, A. B.
(1996)
Proc. Soc. Exp. Biol. Med.
213,
150-177[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Fielding, C. J.,
and Fielding, P. E.
(1997)
J. Lipid. Res.
38,
1503-1521[Abstract]
|
| 4.
|
Smart, E. J.,
and van der Westhuyzen, D. R.
(1998)
in
Intracellular Cholesterol Trafficking
(Chang, T. Y.
, and Freeman, D. A., eds)
, pp. 253-272, Kluwer Academic Publishers, Boston
|
| 5.
|
Stangl, H.,
Cao, G.,
Wyne, K. L.,
and Hobbs, H. H.
(1998)
J. Biol. Chem.
273,
31002-31008[Abstract/Free Full Text]
|
| 6.
|
Schroeder, F.
(1984)
Prog. Lipid Res.
23,
97-113[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Schroeder, F.
(1985)
in
Subcellular Biochemistry
(Roodyn, D. B., ed)
, pp. 51-101, Plenum Press, New York
|
| 8.
|
Schroeder, F.,
and Nemecz, G.
(1990)
in
Advances in Cholesterol Research
(Esfahani, M.
, and Swaney, J., eds)
, pp. 47-87, Telford Press, Caldwell, NJ
|
| 9.
|
Nemecz, G.,
Fontaine, R. N.,
and Schroeder, F.
(1988)
Biochim. Biophys. Acta
943,
511-521[Medline]
[Order article via Infotrieve]
|
| 10.
|
Schroeder, F.,
Goh, E. H.,
and Heimberg, M.
(1979)
FEBS Lett.
97,
233-236[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Schroeder, F.,
Goh, E. H.,
and Heimberg, M.
(1979)
J. Biol. Chem.
254,
2456-2463[Free Full Text]
|
| 12.
|
Hale, J. E.,
and Schroeder, F.
(1982)
Eur. J. Biochem.
122,
649-661[Medline]
[Order article via Infotrieve]
|
| 13.
|
Schroeder, F.,
Nemecz, G.,
Wood, W. G.,
Joiner, C.,
Morrot, G.,
Ayraut-Jarrier, M.,
and Devaux, P. F.
(1991)
Biochim. Biophys. Acta
1066,
183-192[Medline]
[Order article via Infotrieve]
|
| 14.
|
Smutzer, G.,
Crawford, B. F.,
and Yeagle, P. L.
(1986)
Biochim. Biophys. Acta
862,
361-371[Medline]
[Order article via Infotrieve]
|
| 15.
|
Schroeder, F.,
Barenholz, Y.,
Gratton, E.,
and Thompson, T. E.
(1987)
Biochemistry
26,
2441-2448[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Schroeder, F.,
Frolov, A.,
Schoer, J.,
Gallegos, A.,
Atshaves, B. P.,
Stolowich, N. J.,
Scott, A. I.,
and Kier, A. B.
(1998)
in
Intracellular Cholesterol Trafficking
(Chang, T. Y.
, and Freeman, D. A., eds)
, pp. 213-234, Kluwer Academic Publishers, Boston
|
| 17.
|
Wood, W. G.,
Schroeder, F.,
Avdulov, N. A.,
Chochina, S. V.,
and Igbavboa, U.
(1999)
Lipids
34,
225-234[Medline]
[Order article via Infotrieve]
|
| 18.
|
Frolov, A.,
Woodford, J. K.,
Murphy, E. J.,
Billheimer, J. T.,
and Schroeder, F.
(1996)
J. Biol. Chem.
271,
16075-16083[Abstract/Free Full Text]
|
| 19.
|
Frolov, A. A.,
Woodford, J. K.,
Murphy, E. J.,
Billheimer, J. T.,
and Schroeder, F.
(1996)
J. Lipid. Res.
37,
1862-1874[Abstract]
|
| 20.
|
Smith, R. J. M.,
and Green, C.
(1974)
Biochem. J.
137,
413-415[Medline]
[Order article via Infotrieve]
|
| 21.
|
Bergeron, R. J.,
and Scott, J.
(1982)
Anal. Chem.
119,
128-134[CrossRef]
|
| 22.
|
Bergeron, R. J.,
and Scott, J.
(1982)
J. Lipid Res.
23,
391-404[Abstract]
|
| 23.
|
Mukherjee, S.,
Zha, X.,
Tabas, I.,
and Maxfield, F. R.
(1998)
Biophys. J.
75,
1915-1925[Medline]
[Order article via Infotrieve]
|
| 24.
|
Sparrow, C. P.,
Patel, S.,
Baffic, J.,
Chao, Y.-S.,
Hernandez, M.,
Lam, M.-H.,
Montenegro, J.,
Wright, S. D.,
and Detmers, P. A.
(1999)
J. Lipid Res.
40,
1747-1757[Abstract/Free Full Text]
|
| 25.
|
Billheimer, J. T.,
and Gillies, P. J.
(1990)
in
Advances in Cholesterol Research
(Esfahani, M.
, and Swaney, J. B., eds)
, pp. 7-45, The Telford Press, Caldwell, NJ
|
| 26.
|
Schroeder, F.,
Perlmutter, J. F.,
Glaser, M.,
and Vagelos, P. R.
(1976)
J. Biol. Chem.
251,
6739-6746[Abstract/Free Full Text]
|
| 27.
|
Fischer, R. T.,
Cowlen, M. S.,
Dempsey, M. E.,
and Schroeder, F.
(1985)
Biochemistry
24,
3322-3331[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Schroeder, F.,
Perlmutter, J. F.,
Glaser, M.,
and Vagelos, P. R.
(1976)
J. Biol. Chem.
251,
5015-5026[Abstract/Free Full Text]
|
| 29.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Schroeder, F.,
Myers-Payne, S. C.,
Billheimer, J. T.,
and Wood, W. G.
(1995)
Biochemistry
34,
11919-11927[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Masters, B. P.,
and So, P. T. C.
(1997)
Biophys. J.
72,
2405-2412[Medline]
[Order article via Infotrieve]
|
| 32.
|
So, P. T. C.,
French, T., Yu, W. M.,
Berland, K. M.,
Dong, C. Y.,
and Gratton, E.
(1996)
in
Fluorescence Imaging Spectroscopy and Microscopy
(Wang, X. G.
, and Herman, B., eds)
, p. 351, John Wiley & Sons, Inc., Boston
|
| 33.
|
Forster, T.
(1967)
in
Comprehensive Biochemistry
(Florkin, M.
, and Statz, E. H., eds)
, pp. 61-77, Elsevier, New York
|
| 34.
|
Loura, L. M. S.,
and Prieto, M.
(1997)
Biophys. J.
72,
2226-2236[Medline]
[Order article via Infotrieve]
|
| 35.
|
Hara, A.,
and Radin, N. S.
(1978)
Anal. Biochem.
90,
420-426[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Bradford, M. M.
(1976)
Anal. Biochemistry
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Murphy, E. J.
(1998)
Am. J. Physiol.
275,
G237-G243[Abstract/Free Full Text]
|
| 38.
|
Murphy, E. J.,
and Schroeder, F.
(1997)
Biochim. Biophys. Acta
1345,
283-292[Medline]
[Order article via Infotrieve]
|
| 39.
|
Moncecchi, D. M.,
Murphy, E. J.,
Prows, D. R.,
and Schroeder, F.
(1996)
Biochim. Biophys. Acta
1302,
110-116[Medline]
[Order article via Infotrieve]
|
| 40.
|
Denk, W.,
Strickler, J. H.,
and Webb, W. W.
(1990)
Science
248,
73-76[Abstract/Free Full Text]
|
| 41.
|
Maiti, S.,
Shear, J. B.,
Williams, R. M.,
Zipfel, W. R.,
and Webb, W. W.
(1997)
Science
275,
530-532[Abstract/Free Full Text]
|
| 42.
|
Fowler, S. D.,
and Greenspan, P.
(1985)
J. Histochem. Cytochem.
33,
833-836[Abstract]
|
| 43.
|
Brasaemle, D. L.,
Barber, T.,
Wolins, N.,
Serrero, G.,
Blanchette-Mackie, E. J.,
and Londos, C.
(1997)
J. Lipid Res.
38,
2249-2263[Abstract]
|
| 44.
|
Chanderbhan, R.,
Noland, B. J.,
Scallen, T. J.,
and Vahouny, G. V.
(1982)
J. Biol. Chem.
257,
8928-8934[Abstract/Free Full Text]
|
| 45.
|
Londos, C.,
Brasaemle, D. L.,
Schultz, C. J.,
Segrest, J.,
and Kimmel, A. R.
(1999)
Cell Dev. Biol.
10,
51-58
|
| 46.
|
Murphy, E. J.,
and Schroeder, F.
(1997)
Biochim. Biophys. Acta
1345,
283-292
|
| 47.
|
Schnitzer, J. E.,
Allard, J.,
and Oh, P.
(1995)
Am. J. Physiol.
268,
H48-H55[Abstract/Free Full Text]
|
| 48.
|
Schnitzer, J. E.,
Liu, J.,
and Oh, P.
(1995)
J. Biol. Chem.
270,
14399-14404[Abstract/Free Full Text]
|
| 49.
|
Jiang, H. P.,
and Serrero, G.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
7856-7860[Abstract/Free Full Text]
|
| 50.
|
Gao, J.,
and Serrero, G.
(1999)
J. Biol. Chem.
274,
16825-16830[Abstract/Free Full Text]
|
| 51.
|
Krieger, M.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
4077-4080[Free Full Text]
|
| 52.
|
Fielding, C. J.,
Bist, A.,
and Fielding, P. E.
(1998)
in
Intracellular Cholesterol Trafficking
(Chang, T. Y.
, and Freeman, D. A., eds)
, pp. 273-288, Kluwer Academic Publishers, Boston
|
| 53.
|
Rodrigueza, W. V.,
Thuanhnai, S. T.,
Temel, R. E.,
Lund-Katz, S.,
Phillips, M. C.,
and Williams, D. L.
(1999)
J. Biol. Chem.
274,
20344-20350[Abstract/Free Full Text]
|
| 54.
|
Acton, S.,
Rigotti, A.,
Landschulz, K. T.,
Xu, S.,
Hobbs, H. H.,
and Krieger, M.
(1996)
Science
271,
518-520[Abstract]
|
| 55.
|
Reaven, E.,
Tsai, L.,
and Azhar, S.
(1996)
J. Biol. Chem.
271,
16208-16217[Abstract/Free Full Text]
|
| 56.
|
Stolowich, N.,
Frolov, A.,
Petrescu, A.,
Scott, A. I.,
Billheimer, J. T.,
and Schroeder, F.
(1999)
J. Biol. Chem.
274,
35425-35433[Abstract/Free Full Text]
|
| 57.
|
Avdulov, N. A.,
Chochina, S. V.,
Igbavboa, U.,
Warden, C. H.,
Schroeder, F.,
and Wood, W. G.
(1999)
Biochim. Biophys. Acta
1437,
37-45[Medline]
[Order article via Infotrieve]
|
| 58.
|
Acton, S. L.,
Scherer, P. E.,
Lodish, H. F.,
and Krieger, M.
(1994)
J. Biol. Chem.
269,
21003-21009[Abstract/Free Full Text]
|
| 59.
|
Yu, C.,
Chen, J.,
Lin, S.,
Liu, J.,
Chang, C. C. Y.,
and Chang, T.-Y.
(1999)
J. Biol. Chem.
274,
36139-36145[Abstract/Free Full Text]
|
| 60.
|
Frolov, A.,
Cho, T. H.,
Billheimer, J. T.,
and Schroeder, F.
(1996)
J. Biol. Chem.
271,
31878-31884[Abstract/Free Full Text]
|
| 61.
|
Colles, S. M.,
Woodford, J. K.,
Moncecchi, D.,
Myers-Payne, S. C.,
McLean, L. R.,
Billheimer, J. T.,
and Schroeder, F.
(1995)
Lipids
30,
795-804[Medline]
[Order article via Infotrieve]
|
| 62.
|
Stolowich, N. J.,
Frolov, A.,
Atshaves, B. P.,
Murphy, E.,
Jolly, C. A.,
Billheimer, J. T.,
Scott, A. I.,
and Schroeder, F.
(1997)
Biochemistry
36,
1719-1729[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Buers, H. Robenek, S. Lorkowski, Y. Nitschke, N. J. Severs, and O. Hofnagel
TIP47, a Lipid Cargo Protein Involved in Macrophage Triglyceride Metabolism
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2009;
29(5):
767 - 773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Takahashi, M. Murate, M. Fukuda, S. B. Sato, A. Ohta, and T. Kobayashi
Cholesterol Controls Lipid Endocytosis through Rab11
Mol. Biol. Cell,
July 1, 2007;
18(7):
2667 - 2677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hidaka, N. Hanyu, M. Sugano, K. Kawasaki, K. Yamauchi, and T. Katsuyama
Analysis of Human Serum Lipoprotein Lipid Composition Using MALDI-TOF Mass Spectrometry
Ann. Clin. Lab. Sci.,
January 1, 2007;
37(3):
213 - 221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yao, Y. Huang, K. Shioi, K. Hattori, T. Murakami, N. Nakaigawa, T. Kishida, Y. Nagashima, and Y. Kubota
Expression of Adipose Differentiation-Related Protein: A Predictor of Cancer-Specific Survival in Clear Cell Renal Carcinoma
Clin. Cancer Res.,
January 1, 2007;
13(1):
152 - 160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Wei, S. Taniguchi, Y. Sakai, M. Imamura, T. Inoguchi, H. Nawata, S. Oda, Y. Nakabeppu, J. Nishimura, and S. Ikuyama
Expression of Adipose Differentiation-Related Protein (ADRP) Is Conjointly Regulated by PU.1 and AP-1 in Macrophages
J. Biochem.,
October 1, 2005;
138(4):
399 - 412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ozeki, J. Cheng, K. Tauchi-Sato, N. Hatano, H. Taniguchi, and T. Fujimoto
Rab18 localizes to lipid droplets and induces their close apposition to the endoplasmic reticulum-derived membrane
J. Cell Sci.,
June 15, 2005;
118(12):
2601 - 2611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Robenek, M. J. Robenek, and D. Troyer
PAT family proteins pervade lipid droplet cores
J. Lipid Res.,
June 1, 2005;
46(6):
1331 - 1338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. Hostetler, A. D. Petrescu, A. B. Kier, and F. Schroeder
Peroxisome Proliferator-activated Receptor {alpha} Interacts with High Affinity and Is Conformationally Responsive to Endogenous Ligands
J. Biol. Chem.,
May 13, 2005;
280(19):
18667 - 18682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Dagher, N. Donne, C. Klein, P. Ferre, and I. Dugail
HDL-mediated cholesterol uptake and targeting to lipid droplets in adipocytes
J. Lipid Res.,
October 1, 2003;
44(10):
1811 - 1820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. DiDonato and D. L. Brasaemle
Fixation Methods for the Study of Lipid Droplets by Immunofluorescence Microscopy
J. Histochem. Cytochem.,
June 1, 2003;
51(6):
773 - 780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sugii, P. C. Reid, N. Ohgami, Y. Shimada, R. A. Maue, H. Ninomiya, Y. Ohno-Iwashita, and T.-Y. Chang
Biotinylated {theta}-toxin derivative as a probe to examine intracellular cholesterol-rich domains in normal and Niemann-Pick type C1 cells
J. Lipid Res.,
May 1, 2003;
44(5):
1033 - 1041.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. McIntosh, A. M. Gallegos, B. P. Atshaves, S. M. Storey, D. Kannoju, and F. Schroeder
Fluorescence and Multiphoton Imaging Resolve Unique Structural Forms of Sterol in Membranes of Living Cells
J. Biol. Chem.,
February 14, 2003;
278(8):
6384 - 6403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Wustner, A. Herrmann, M. Hao, and F. R. Maxfield
Rapid Nonvesicular Transport of Sterol between the Plasma Membrane Domains of Polarized Hepatic Cells
J. Biol. Chem.,
August 9, 2002;
277(33):
30325 - 30336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Huang, O. Starodub, A. McIntosh, A. B. Kier, and F. Schroeder
Liver Fatty Acid-binding Protein Targets Fatty Acids to the Nucleus. REAL TIME CONFOCAL AND MULTIPHOTON FLUORESCENCE IMAGING IN LIVING CELLS
J. Biol. Chem.,
August 2, 2002;
277(32):
29139 - 29151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Schultz, E. Torres, C. Londos, and J. S. Torday
Role of adipocyte differentiation-related protein in surfactant phospholipid synthesis by type II cells
Am J Physiol Lung Cell Mol Physiol,
August 1, 2002;
283(2):
L288 - L296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Petrescu, R. Hertz, J. Bar-Tana, F. Schroeder, and A. B. Kier
Ligand Specificity and Conformational Dependence of the Hepatic Nuclear Factor-4alpha (HNF-4alpha )
J. Biol. Chem.,
June 28, 2002;
277(27):
23988 - 23999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Souza, K. V. Muliro, L. Liscum, P. Lien, M. T. Yamamoto, J. E. Schaffer, G. E. Dallal, X. Wang, F. B. Kraemer, M. Obin, et al.
Modulation of Hormone-sensitive Lipase and Protein Kinase A-mediated Lipolysis by Perilipin A in an Adenoviral Reconstituted System
J. Biol. Chem.,
March 1, 2002;
277(10):
8267 - 8272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Schroeder, A. M. Gallegos, B. P. Atshaves, S. M. Storey, A. L. McIntosh, A. D. Petrescu, H. Huang, O. Starodub, H. Chao, H. Yang, et al.
Recent Advances in Membrane Microdomains: Rafts, Caveolae, and Intracellular Cholesterol Trafficking
Experimental Biology and Medicine,
November 1, 2001;
226(10):
873 - 890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. van Meer
Caveolin, Cholesterol, and Lipid Droplets?
J. Cell Biol.,
March 5, 2001;
152(5):
F29 - F34.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Starodub, C. A. Jolly, B. P. Atshaves, J. B. Roths, E. J. Murphy, A. B. Kier, and F. Schroeder
Sterol carrier protein-2 localization in endoplasmic reticulum and role in phospholipid formation
Am J Physiol Cell Physiol,
October 1, 2000;
279(4):
C1259 - C1269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Atshaves, O. Starodub, A. McIntosh, A. Petrescu, J. B. Roths, A. B. Kier, and F. Schroeder
Sterol Carrier Protein-2 Alters High Density Lipoprotein-mediated Cholesterol Efflux
J. Biol. Chem.,
November 17, 2000;
275(47):
36852 - 36861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Atshaves, S. M. Storey, A. L. McIntosh, A. D. Petrescu, O. I. Lyuksyutova, A. S. Greenberg, and F. Schroeder
Sterol Carrier Protein-2 Expression Modulates Protein and Lipid Composition of Lipid Droplets
J. Biol. Chem.,
June 29, 2001;
276(27):
25324 - 25335.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|